Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-08 Sale | 2025-09-09 7:02 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,294 | $15.84 | $115,537 | 551,440 (Direct) | View |
| 2025-08-25 Sale | 2025-08-26 8:00 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 1,480 | $13.42 | $19,862 | 87,291 (Direct) | View |
| 2025-08-25 Sale | 2025-08-26 7:59 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,954 | $13.42 | $26,223 | 166,427 (Direct) | View |
| 2025-08-25 Sale | 2025-08-26 7:57 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,336 | $13.42 | $31,349 | 177,505 (Direct) | View |
| 2025-08-22 Sale | 2025-08-25 9:33 pm | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 1,864 | $13.22 | $24,647 | 116,271 (Direct) | View |
| 2025-08-22 Sale | 2025-08-25 7:46 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,362 | $13.22 | $31,232 | 183,381 (Direct) | View |
| 2025-08-22 Sale | 2025-08-25 7:46 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 10,940 | $13.22 | $144,657 | 712,358 (Direct) | View |
| 2025-08-22 Sale | 2025-08-25 7:45 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,942 | $13.22 | $38,901 | 207,341 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 4:27 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,649 | $13.19 | $34,932 | 137,246 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 4:26 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,939 | $13.19 | $38,757 | 127,818 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 4:26 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 4,409 | $13.19 | $58,141 | 388,750 (Direct) | View |
| 2025-07-09 Sale | 2025-07-10 8:56 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 32,979 | $15.69 | $517,523 | 369,595 (Direct) | View |
| 2025-07-09 Sale | 2025-07-10 8:50 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 30,250 | $15.69 | $474,698 | 127,939 (Direct) | View |
| 2025-06-09 Sale | 2025-06-10 5:00 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 7,169 | $14.5 | $103,951 | 486,950 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 4:06 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,146 | $11.31 | $24,272 | 173,026 (Direct) | View |
| 2025-05-23 Sale | 2025-05-27 4:05 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,926 | $11.31 | $21,782 | 135,689 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 4:26 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,689 | $11.88 | $31,933 | 203,922 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 4:25 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,317 | $11.88 | $27,516 | 153,240 (Direct) | View |
| 2025-05-22 Sale | 2025-05-23 4:24 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 9,999 | $11.88 | $118,743 | 655,368 (Direct) | View |
| 2025-05-19 Sale | 2025-05-20 7:28 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,600 | $11.84 | $30,791 | 107,513 (Direct) | View |
| 2025-05-19 Sale | 2025-05-20 7:28 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 3,808 | $11.84 | $45,097 | 316,931 (Direct) | View |
| 2025-05-19 Sale | 2025-05-20 7:27 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,776 | $11.84 | $32,876 | 124,342 (Direct) | View |
| 2025-04-09 Purchase | 2025-04-11 5:22 pm | KalVista Pharmaceuticals Inc. | KALV | Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC VHCP Management EG LLC Venrock Healthcare Capital Partners EG L.P. VHCP Management III LLC Koh Bong Y Shah Nimish P 10% Owner | 25,000 | $9.42 | $235,500 | 5,303,985 (Indirect) | View |
| 2025-03-07 Sale | 2025-03-10 6:43 pm | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 6,669 | $11.97 | $79,828 | 475,312 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:37 pm | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 2,394 | $10.02 | $23,988 | 267,940 (Direct) | View |
| 2025-02-24 Sale | 2025-02-25 8:36 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 1,918 | $10.02 | $19,218 | 194,577 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 8:47 pm | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 2,601 | $9.8242 | $25,553 | 108,906 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-10-08 Option Award | 2025-10-08 6:59 pm | N/A 2035-10-07 | KalVista Pharmaceuticals Inc. | KALV | Arif Bilal Chief Operations Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 6:31 pm | N/A 2035-09-30 | KalVista Pharmaceuticals Inc. | KALV | Pereira Brian JG Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 6:30 pm | N/A 2035-09-30 | KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 6:30 pm | N/A 2035-09-30 | KalVista Pharmaceuticals Inc. | KALV | Treanor Patrick Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 6:29 pm | N/A 2035-09-30 | KalVista Pharmaceuticals Inc. | KALV | Fairey William Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 6:28 pm | N/A 2035-09-30 | KalVista Pharmaceuticals Inc. | KALV | Unkart Edward W Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2025-10-01 Option Award | 2025-10-02 6:28 pm | N/A 2035-09-30 | KalVista Pharmaceuticals Inc. | KALV | Sensenig Bethany Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2025-09-06 Exercise | 2025-09-09 7:02 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 551,440 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 8:00 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 5,000 | $0 | 87,291 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 7:59 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 166,427 (Direct) | View |
| 2025-08-22 Exercise | 2025-08-26 7:57 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 177,505 (Direct) | View |
| 2025-08-21 Exercise | 2025-08-25 9:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 6,250 | $0 | 116,271 (Direct) | View |
Ownership | 2025-08-25 9:33 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Sweeny Nicole Chief Commercial Officer | 0 | $0 | 280,000 (Direct) | View |
| 2025-08-21 Exercise | 2025-08-25 7:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,750 | $0 | 183,381 (Direct) | View |
| 2025-08-21 Exercise | 2025-08-25 7:46 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 23,250 | $0 | 712,358 (Direct) | View |
| 2025-08-21 Exercise | 2025-08-25 7:45 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 6,250 | $0 | 207,341 (Direct) | View |
| 2025-08-17 Exercise | 2025-08-19 4:27 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 8,406 | $0 | 137,246 (Direct) | View |
| 2025-08-17 Exercise | 2025-08-19 4:26 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 12,892 | $0 | 127,818 (Direct) | View |
| 2025-08-17 Exercise | 2025-08-19 4:26 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 18,724 | $0 | 388,750 (Direct) | View |
| 2025-08-11 Option Award | 2025-08-13 5:29 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 227,840 | $0 | 227,840 (Direct) | View |
| 2025-07-08 Option Award | 2025-07-10 8:56 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 87,500 | $0 | 369,595 (Direct) | View |
| 2025-07-08 Option Award | 2025-07-10 8:50 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 60,000 | $0 | 127,939 (Direct) | View |
| 2025-06-06 Exercise | 2025-06-10 5:00 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 486,950 (Direct) | View |
| 2025-05-22 Exercise | 2025-05-27 4:06 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 173,026 (Direct) | View |
| 2025-05-22 Exercise | 2025-05-27 4:05 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 135,689 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-23 4:26 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 6,250 | $0 | 203,922 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-23 4:25 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,750 | $0 | 153,240 (Direct) | View |
| 2025-05-21 Exercise | 2025-05-23 4:24 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 23,250 | $0 | 655,368 (Direct) | View |
| 2025-05-17 Exercise | 2025-05-20 7:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 8,410 | $0 | 107,513 (Direct) | View |
| 2025-05-17 Exercise | 2025-05-20 7:28 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 18,728 | $0 | 316,931 (Direct) | View |
| 2025-05-17 Exercise | 2025-05-20 7:27 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 12,894 | $0 | 124,342 (Direct) | View |
| 2025-03-06 Exercise | 2025-03-10 6:43 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 15,625 | $0 | 475,312 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 100,000 | $0 | 267,940 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 8:37 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Audhya Paul K. CHIEF MEDICAL OFFICER | 5,000 | $0 | 267,940 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Palleiko Benjamin L CHIEF EXECUTIVE OFFICER | 372,000 | $0 | 372,000 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 60,000 | $0 | 194,577 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 8:36 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 3,125 | $0 | 194,577 (Direct) | View |
| 2025-02-21 Option Award | 2025-02-25 8:35 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Piekos Brian Chief Financial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2025-02-17 Exercise | 2025-02-19 8:47 pm | N/A N/A | KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER | 8,408 | $0 | 108,906 (Direct) | View |